Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001562230-25-000070·BeOne Medicines Ltd.
Schedule 13G ownership disclosure
BeiGene, Ltd.
Common Stock · CUSIP: G1146Y101
Event date: 2025-03-31
- Filing-level shares
- 81,647,620.00
- Percent of class
- 5.8%
- Capital International Investors
Shares: 81,647,620.00 · Class: 5.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001562230-25-000070
- Form type
- SCHEDULE 13G/A
- Filer
- BeOne Medicines Ltd.
- CIK
- CIK 1651308
- Filed
- May 13, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership